期刊文献+

胰岛素抵抗、PAI-1与糖尿病肾病的相关性研究 被引量:4

Relationship between insulin r`esistance,type-1 plasminogen activator inhibitor and diabetic nephropathy
下载PDF
导出
摘要 目的探讨胰岛素抵抗(IR)程度、血浆组织纤溶酶原激活物抑制剂-1(PAI-1)水平与2型糖尿病肾病(DN)患者病情严重程度的相关性。方法连续收集2010年1月至2012年11月在我院肾内科病区及内分泌科病区住院并诊断为DN的患者122例,按尿蛋白排泄率(UAER)水平分为微量白蛋白尿组(60例)和大量白蛋白尿组(62例)两组,检测DN患者血浆空腹胰岛素(Fins)、PAI-1水平并计算胰岛素抵抗指数(HOMA-IR),比较两组患者上述指标的差异,采用多因素Logistic回归分析方法分析HOMA-IR、PAI-1水平、低密度脂蛋白、总胆固醇、高血压、性别等多个自变量与DN患者病情严重程度(UAER>200μg/min)的相关性。结果大量白蛋白尿组DN患者血浆Fins、PAI-1水平及HOMA-IR均明显高于微量白蛋白组(P<0.01),Spearman相关分析显示DN患者HOMA-IR与PAI-1呈正相关(r=0.495,P<0.05),多因素Logistic回归分析显示HOMA-IR,PAI-1与糖尿病病程均是DN严重程度的独立预测因子。结论胰岛素抵抗、PAI-1是DN形成和发展的重要因素,两者相互作用加重DN的病情。 Objective To investigate the relationship between insulin resistance,type-1 plasminogen activator inhibitor(PAI-1) and the severity of diabetic nephropathy(DN).Methods 122 DN patients hospitalized in our urology department or endocrinology department from January,2010 to November,2012 were selected and divided into two groups according to patients' urinary albumin excretion rate(UAER) levels: microalbuminuria group including 60 cases and massive albuminuria group including 62 cases.DN patients' plasma fasting insulin(Fins) and PAI-1 levels were measured after admission,Homeostasis Model Assessment(HOMA) were used to calculate insulin resistance index(HOMA-IR).Multiple factor Logistic regression analysis were used to measure the predictive value of PAI-1,HOMA-IR to the severity of DN.Results HOMA-IR,Plasma levels of PAI-1 and Fins in massive albuminuria group were significantly higher than microalbuminuria group(P0.01).Spearman correlation analysis indicated that HOMA-IR had a positive correlation with PAI-1 level(r=0.495,P0.05).Multiple factor Logistic regression analysis indicated that PAI-1,HOMA-IR and course of type-2 diabetes mellitus were independent factors relevant to the severity of DN.Conclusions Both insulin resistance and PAI-1 were crucial factors in DN's development and progression.The interactions between IR and PAI-1 aggravated DN patients' condition.
出处 《齐齐哈尔医学院学报》 2013年第13期1873-1875,共3页 Journal of Qiqihar Medical University
关键词 糖尿病肾病 胰岛素抵抗 纤溶酶原激活物抑制剂-1 Diabetic nephropathy Insulin resistance Type I plasminogen activator inhibitor
  • 相关文献

参考文献9

  • 1佟之复,李宁华,苗俊梅,张培兰.2型糖尿病肾病流行病学研究进展[J].中国老年学杂志,2001,21(3):241-242. 被引量:40
  • 2Hyo Sun Choia,Seung Ho Ryub,Kyu-Beck Leea.The relationship of microalbuminuria with metabolic syndrome.Nephron Clin Pract,2006,104(15):85-93.
  • 3Tsuyoshi O,Michael F,Wilbur L,et al.Modulation of plasminogen activator inhibitor-1 in vivo:A new mechanism for the antipfibrotic effect of renin -angiotensin inhibitor.Kidney Int,1997,51(2):164-172.
  • 4Auzuki M,Akimito K,Hattoi Y.Glucose upregulates plasminogen activator-1 gene expression in vascular smooth muscle cells.Life Sci,2002,72:59-66.
  • 5刘国仗.胰岛素抵抗及其检测方法[J].中华心血管病杂志,1996,24(1):3-4. 被引量:125
  • 6Parvanova AI,Trevisan R,Iliev IP,et al.Insulin resistance and microalbuminuria:a across-sectional,case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion.Diabetes,2006,55(5):1456-1462.
  • 7Bastard JP,Pieroni L,Hainque B.Relationship between plasma plasminogen activator inhibitor-1 and insulin resistance.Diabetes Metab Res Rev,2000,16(3):192-201.
  • 8Kessler L,Azimzadeh A,Wiesel ML,et al.Effect of insulin on von willebrand factor release in normal and diabetic subjects:in vivo and in vitro studies.Horm Metab Res,2001,33(11):674-680.
  • 9Samad,Pandey M,Bell PA,et al.Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin resistant mice and adipocytes.Mol Med,2000,6(8):680-692.

二级参考文献19

  • 1[1]Bakris GL,Stein JH.Diabetic nephropathy[J].Dis Mon,1993;39(8):573-611
  • 2[2]Brancati FL,Cusumano AM.Epidemiology and prevention of diabetic nephropathy[J].Curr Opin Nephrol Hypertens,1995;4(3):223-229
  • 3[3]Breyer JA.Diabetic nephropathy in insulin-dependent patients[J].Am J Kindey Dis,1992;20:533-547
  • 4[4]Hostetter TH.Early renal function in diabetes and risk factors for development of diabetic nephropathy.in:Jacobson HR,Striker CE,Klahr S,eds.The principles and practice of nephrology[M].Philadelphia BC Decker,1991:460-462
  • 5[5]Mongensen CE.Microalbuminuria as a predictor of clinical diabetic nephropathy[J].Kidney Int,1987;31(2):673-689
  • 6[6]Viberti GC,Wiseman M.The kidney in diabetes:Significance of early abnormalities[J].Clin Endocrinol Metab,1986;9:85-92
  • 7[7]Nielsen S,Schmitz A,Mogensen CE.Rate of progression of nephropathy in normal and microalbuminurial type Ⅱ diabetic patients.Diabetologia[J],1991;34(suppl 2):A144
  • 8[8]Schmitz A.Microalbuminuria and mortality in non-insulin-depen dent diabetes.In:Mogensen CE,ed.The Kidney and Hypertension in Diabetesc[M].Boston:Martinus Nijhoff Publishing,1988:6570
  • 9[9]Christensen CK,Mogensen CE.The course of incipients nephropathy:studies on albumin excretion and blood pressure[J].Diabetic Med,1985;2:97-102
  • 10[10]Gilbert RE,Tsalamandris C,Bach LA et al.Long-term glycaemic control and the rate of progression of early diabetic kidney disease[J].Kidney Int,1993;44:855-859

共引文献163

同被引文献57

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部